Comparing Alaway vs Opcon-A
| Alaway (ketotifen) | Opcon-A (naphazoline / pheniramine) |
|
|---|
| Alaway (ketotifen) | Opcon-A (naphazoline / pheniramine) |
|
|---|---|---|
|
Over-the-counter
Prescribed for Conjunctivitis - Allergic. Alaway may also be used for purposes not listed in this medication guide. |
Over-the-counter
Prescribed for Eye Redness/Itching. Opcon-A may also be used for purposes not listed in this medication guide. |
|
| More about Alaway (ketotifen) | More about Opcon-A (naphazoline / pheniramine) | |
| Ratings & Reviews | ||
|
Alaway has an average rating of 10.0 out of 10 from a total of 3 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Opcon-A has an average rating of 5.4 out of 10 from a total of 34 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 38% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
|
View all Alaway side effects |
View all Opcon-A side effects |
|
| Drug Class | ||
| Generic Availability | ||
|
N/A |
N/A |
|
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
N/A |
|
| Brand Names | ||
| Other ketotifen brands include: Claritin Eye, Eye Itch Relief, Refresh Eye Itch Relief, Thera Tears Allergy Eye Itch Relief, Visine All Day Eye Itch Relief, Zaditor | Other naphazoline / pheniramine brands include: AK-Con-A, Eye Allergy Relief, Naphcon-A, Visine-A | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
N/A |
N/A |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | ||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
|
|
| Drug Interactions | ||
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 49 drugs are known to interact with Opcon-A:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
| Disease Interactions | ||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||
| First Approval Date | ||
|
N/A |
N/A |
|
| WADA Class View classifications | ||
|
N/A |
N/A |
|
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
|
N/A |
||
| Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.